Antimicrobials - First Aid Flashcards

(254 cards)

1
Q

Antimicrobial Therapy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antimicrobials:

IV Penicillin

A

Penicillin G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antimicrobials:

IM Penicillin

A

Penicillin G

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antimicrobials:

Oral Penicillin

A

Penicillin V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antimicrobials:

prototype β-lactam antibiotics

A
  • Penicillin G (IV and IM form)
  • Penicillin V (oral form)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antimicrobials:

Mechanism of Action

  • D-Ala-D-Ala structural analog
  • bind _____-binding proteins (transpeptidases)
  • block transpeptidase cross-linking of peptidoglycan in cell wall
  • activate autolytic enzymes
A
  • Penicillin G
  • Penicillin V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antimicrobials:

Clinical Use

  • mostly used for gram ⊕ organisms (S. pneumoniae, S. pyogenes, Actinomyces)
  • also used for gram ⊝ cocci (N. meningitidis) and spirochetes (T. pallidum)
  • bactericidal for gram ⊕ cocci, gram ⊕ rods, gram ⊝ cocci, and spirochetes
  • β-lactamase sensitive
A
  • Penicillin G
  • Penicillin V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antimicrobials:

Adverse Effects

  • hypersensitivity reactions
  • direct Coombs ⊕ hemolytic anemia
  • drug-induced interstitial nephritis
A
  • Penicillin G
  • Penicillin V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antimicrobials:

Resistance

  • β-lactamase cleaves the β-lactam ring
  • mutations in _____-binding proteins
A
  • Penicillin G
  • Penicillin V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Penicillinase-Sensitive Penicillins

A
  • Amoxicillin
  • Ampicillin
  • Aminopenicillins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antimicrobials:

Mechanism of Action

  • same as penicillin
  • wider spectrum
  • combine with clavulanic acid to protect against destruction by β-lactamas
A

Penicillinase-Sensitive Penicillins

  • Amoxicillin
  • Ampicillin
  • Aminopenicillins

AMinoPenicillins are AMPed-up penicillin.
AmOxicillin has greater Oral bioavailability than ampicillin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antimicrobials:

Clinical Use

  • extended-spectrum penicillin
    • H. influenzae
    • H. pylori
    • E. coli
    • Listeria monocytogenes
    • Proteus mirabilis
    • Salmonella
    • Shigella
    • Enterococci
A

Penicillinase-Sensitive Penicillins

  • Amoxicillin
  • Ampicillin
  • Aminopenicillins

Ampicillin/Amoxicillin HHELPSS kill Enterococci.

  • H. influenzae
  • H. pylori
  • E. coli
  • Listeria monocytogenes
  • Proteus mirabilis
  • Salmonella
  • Shigella
  • Enterococci
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antimicrobials:

Adverse Effects

  • hypersensitivity reactions
  • rash
  • pseudomembranous colitis
A

Penicillinase-Sensitive Penicillins

  • Amoxicillin
  • Ampicillin
  • Aminopenicillins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antimicrobials:

Resistance

  • Penicillinase (a type of β-lactamase) cleaves β-lactam ring
A

Penicillinase-Sensitive Penicillins

  • Amoxicillin
  • Ampicillin
  • Aminopenicillins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Penicillinase-Resistant Penicillins

A
  • Dicloxacillin
  • Nafcillin
  • Oxacillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antimicrobials:

Mechanism of Action

  • same as penicillin
  • narrow spectrum
  • bulky R group blocks access of β-lactamase to β-lactam ring
A

Penicillinase-Resistant Penicillins

  • Dicloxacillin
  • Nafcillin
  • Oxacillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Antimicrobials:

Clinical Use

  • S. aureus (except MRSA)
A

Penicillinase-Resistant Penicillins

  • Dicloxacillin
  • Nafcillin
  • Oxacillin

“Use naf (Nafcillin) for staph.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antimicrobials:

Adverse Effects

  • hypersensitivity reactions
  • interstitial nephritis
A

Penicillinase-Resistant Penicillins

  • Dicloxacillin
  • Nafcillin
  • Oxacillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Antimicrobials:

Resistance

  • MRSA has altered penicillin-binding protein target site
A

Penicillinase-Resistant Penicillins

  • Dicloxacillin
  • Nafcillin
  • Oxacillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Antipseudomonal Penicillins

A
  • Piperacillin
  • Ticarcillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Antimicrobials:

Mechanism of Action

  • same as penicillin
  • extended spectrum
  • penicillinase sensitive
  • use with β-lactamase inhibitors
A

Antipseudomonal Penicillins

  • Piperacillin
  • Ticarcillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Antimicrobials:

Clinical Use

  • Pseudomonas spp.
  • Gram ⊝ Rods
A

Antipseudomonal Penicillins

  • Piperacillin
  • Ticarcillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Antimicrobials:

Adverse Effects

  • hypersensitivity reactions
A

Antipseudomonal Penicillins

  • Piperacillin
  • Ticarcillin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

_____ are often added to penicillin antibiotics to protect the antibiotic from destruction by β-lactamase (penicillinase).

A

β-Lactamase Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
β-Lactamase Inhibitors
**CAST** * **C**lavulanic Acid * **A**vibactam * **S**ulbactam * **T**azobactam
26
Antimicrobials: _Mechanism of Action_ * β-lactam drugs that inhibit cell wall synthesis but are less susceptible to penicillinases * bactericidal
Cephalosporins
27
Organisms typically not covered by 1st–4th generation cephalosporins are \_\_\_\_\_.
**LAME**: * **L**isteria * **A**typicals (*Chlamydia*, *Mycoplasma*) * **M**RSA * **E**nterococci
28
1st Generation Cephalosporins
* Cefazolin * Cephalexin
29
2nd Generation Cephalosporins
* Ce**fac**lor * Ce**fox**itin * Ce**fur**oxime * Cefo**te**tan **2nd** graders wear **fake** **fox** **fur** to t**e**a parties.
30
3rd Generation Cephalosporins
* Cef**taz**idime * Cefpo**do**xime * Cefo**taxi**me * Cef**tri**axone **Taz**'s torna**do** blows **taxi**s and **tree**s (**3**) away.
31
4th Generation Cephalosporins
Cefepime
32
5th Generation Cephalosporins
Ceftaroline
33
Antimicrobials: _Clinical Use_ * Gram ⊕ Cocci * *Proteus mirabilis* * *E. coli* * *Klebsiella pneumoniae* * used prior to surgery to prevent *S. aureus* wound infections
1st Generation Cephalosporins * Cefazolin—prior to surgery, S. aureus * Cephalexin **PEcK**: * ***P**roteus mirabilis* * ***E**. **c**oli* * ***K**lebsiella pneumoniae*
34
Antimicrobials: _Clinical Use_ * Gram ⊕ Cocci * *H. influenzae* * *Enterobacter aerogenes* * *Neisseria* spp. * *Serratia marcescens* * *Proteus mirabilis* * *E. coli* * *Klebsiella pneumoniae*
2nd Generation Cephalosporins * Cefaclor * Cefoxitin * Cefuroxime * Cefotetan **HENS PEcK**: * ***H**. influenzae* * ***E**nterobacter aerogenes* * ***N**eisseria* spp. * ***S**erratia marcescens* * ***P**roteus mirabilis* * ***E**. **c**oli* * ***K**lebsiella pneumoniae*
35
Antimicrobials: _Clinical Use_ * serious gram ⊝ infections resistant to other β-lactams * can cross blood-brain barrier
3rd Generation Cephalosporins * Ceftazidime—*Pseudomonas* * Cefpodoxime * Cefotaxime * Ceftriaxone—meningitis, gonorrhea, disseminated Lyme disease
36
Antimicrobials: _Clinical Use_ * Gram ⊝ * ↑ activity against *Pseudomonas* and gram ⊕ organisms
4th Generation Cephalosporins * Cefepime
37
Antimicrobials: _Clinical Use_ * broad gram ⊕ and gram ⊝ organism coverage * *Listeria* * MRSA * *Enterococcus faecalis* * does not cover *Pseudomonas*
5th Generation Cephalosporins * Ceftaroline
38
Antimicrobials: _Adverse Effects_ * hypersensitivity reactions * autoimmune hemolytic anemia * disulfiram-like reaction * vitamin K deficiency * low rate of cross-reactivity even in penicillin-allergic patients * ↑ nephrotoxicity of aminoglycosides
Cephalosporins
39
Antimicrobials: _Resistance_ * inactivated by \_\_\_\_\_ases (a type of β-lactamase) * structural change in penicillin-binding proteins (transpeptidases)
Cephalosporins
40
Carbapenems
**DIME:** * **D**oripenem * **I**mipenem * **M**eropenem * **E**rtapenem **DIME** antibiotics are given when there is a **10**/10 (life-threatening) infection.
41
Antimicrobials: _Mechanism of Action_ * broad-spectrum * β-lactamase–resistant * always administered with Cilastatin (inhibitor of renal dehydropeptidase I) to ↓ inactivation of drug in renal tubules
Carbapenems * Imipenem With imipenem, “the kill is **lastin’** with **Cilastatin**.” Newer Carbapenems * Ertapenem (limited *Pseudomonas* coverage) * Doripenem
42
Antimicrobials: _Clinical Use_ * Gram ⊕ Cocci * Gram ⊝ Rods * Anaerobes * wide spectrum and significant side effects limit use to life-threatening infections or after other drugs have failed
Carbapenems * Doripenem * Imipenem * Meropenem—↓ risk of seizures, stable to dehydropeptidase I * Ertapenem
43
Antimicrobials: _Adverse Effects_ * GI distress * rash * CNS toxicity (seizures) at high plasma levels
Carbapenems * Doripenem * Imipenem * Meropenem * Ertapenem
44
Monobactams
Aztreonam
45
Antimicrobials: _Mechanism of Action_ * less susceptible to β-lactamases * prevents peptidoglycan cross-linking by binding to penicillin-binding protein 3 * synergistic with aminoglycosides * no cross-allergenicity with penicillins
Monobactams * Aztreonam
46
Antimicrobials: _Clinical Use_ * Gram ⊝ Rods * no activity against gram ⊕ rods or anaerobes * for penicillin-allergic patients and those with renal insufficiency who cannot tolerate aminoglycosides
Monobactams * Aztreonam
47
Antimicrobials: _Adverse Effects_ * usually nontoxic * occasional GI upset
Monobactams * Aztreonam
48
Antimicrobials: _Mechanism of Action_ * inhibits cell wall peptidoglycan formation by binding D-Ala-D-Ala portion of cell wall precursors * bactericidal against most bacteria (bacteriostatic against *C. difficile*) * not susceptible to β-lactamases
Vancomycin
49
Antimicrobials: _Clinical Use_ * Gram ⊕ * serious, multidrug-resistant organisms, including MRSA, *S. epidermidis*, sensitive *Enterococcus* species, and *Clostridium difficile* (oral dose for pseudomembranous colitis)
Vancomycin
50
Antimicrobials: _Adverse Effects_ * well tolerated in general * nephrotoxicity * ototoxicity * thrombophlebitis * Red Man Syndrome * diffuse flushing * largely preventable by pretreatment with antihistamines and slow infusion rate * DRESS Syndrome * drug reaction with eosinophilia and systemic symptoms
Vancomycin
51
Antimicrobials: _Resistance_ * occurs in bacteria (eg, *Enterococcus)* via amino acid modification of D-Ala-D-Ala to D-Ala-D-Lac
Vancomycin If you **Lac**k a **D-Ala** (dollar), you can’t ride the **van**.
52
Protein Synthesis Inhibitors
53
\_\_\_\_\_ specifically target smaller bacterial ribosome (70S, made of 30S and 50S subunits), leaving human ribosome (80S) unaffected.
Protein Synthesis Inhibitors
54
Protein synthesis inhibitors are all bacteriostatic, except \_\_\_\_\_.
* Aminoglycosides (bactericidal) * Linezolid (variable)
55
Protein Synthesis Inhibitors
30S inhibitors * **A**minoglycosides * **T**etracyclines 50S inhibitors * **C**hloramphenicol * **C**lindamycin * **E**rythromycin (Macrolides) * **L**inezolid “Buy **AT 30**, **CCEL** (sell) at **50**.”
56
Aminoglycosides
**GNATS:** * **G**entamicin * **N**eomycin * **A**mikacin * **T**obramycin * **S**treptomycin
57
Antimicrobials: _Mechanism of Action_ * bactericidal * irreversible inhibition of initiation complex through binding of the 30S subunit * can cause misreading of mRNA * also block translocation * require O2 for uptake * ineffective against anaerobes
Aminoglycosides * Gentamicin * Neomycin * Amikacin * Tobramycin * Streptomycin
58
Antimicrobials: _Clinical Use_ * severe gram ⊝ rod infections * synergistic with β-lactam antibiotics * bowel surgery
Aminoglycosides * Gentamicin * Neomycin—bowel surgery * Amikacin * Tobramycin * Streptomycin
59
Antimicrobials: _Adverse Effects_ * nephrotoxicity * neuromuscular blockade * ototoxicity (especially when used with loop diuretics) * teratogen
Aminoglycosides * **G**entamicin * **N**eomycin * **A**mikacin * **T**obramycin * **S**treptomycin “**Mean**” (a**min**oglycoside) **GNATS** ca**NNOT** kill anaerobes. * **N**ephrotoxicity * **N**euromuscular blockade * **O**totoxicity * **T**eratogen
60
Antimicrobials: _Resistance_ * bacterial transferase enzymes inactivate the drug by acetylation, phosphorylation, or adenylation
Aminoglycosides * Gentamicin * Neomycin * Amikacin * Tobramycin * Streptomycin
61
Tetracyclines
* Tetracycline * Doxycycline * Minocycline
62
Antimicrobials: _Mechanism of Action_ * bacteriostatic * bind to 30S and prevent attachment of aminoacyl-tRNA * limited CNS penetration * not taken with milk (Ca2+), antacids (Ca2+ or Mg2+), or iron-containing preparations because divalent cations inhibit drugs’ absorption in the gut
Tetracyclines * Tetracycline * Doxycycline—fecally eliminated, can be used in patients with renal failure * Minocycline
63
Antimicrobials: _Clinical Use_ * *Borrelia burgdorferi* * *M. pneumoniae* * drugs’ ability to accumulate intracellularly makes them very effective against *Rickettsia* and *Chlamydia* * also used to treat acne
Tetracyclines * Tetracycline * Doxycycline—MRSA * Minocycline
64
Antimicrobials: _Adverse Effects_ * GI distress * discoloration of teeth and inhibition of bone growth in children * photosensitivity * contraindicated in pregnancy
Tetracyclines * Tetracycline * Doxycycline * Minocycline
65
Antimicrobials: _Resistance_ * ↓ uptake or ↑ efflux out of bacterial cells by plasmid-encoded transport pumps
Tetracyclines * Tetracycline * Doxycycline * Minocycline
66
Glycylcyclines
Tigecycline
67
Antimicrobials: _Mechanism of Action_ * tetracycline derivative * binds to 30S, inhibiting protein synthesis * generally bacteriostatic
Glycylcyclines * Tigecycline
68
Antimicrobials: _Clinical Use_ * broad-spectrum anaerobic, gram ⊝, and gram ⊕ coverage * multidrug-resistant organisms (MRSA, VRE) or infections requiring deep tissue penetration
Glycylcyclines * Tigecycline
69
Antimicrobials: _Adverse Effects_ * GI symptoms: nausea, vomiting
Glycylcyclines * Tigecycline
70
Antimicrobials: _Mechanism of Action_ * blocks peptidyltransferase at 50S ribosomal subunit * bacteriostatic
Chloramphenicol
71
Antimicrobials: _Clinical Use_ * meningitis (*Haemophilus influenzae*, *Neisseria meningitidis*, *Streptococcus pneumoniae*) and rickettsial diseases (eg. Rocky Mountain Spotted Fever [*Rickettsia rickettsii*]). * limited use due to toxicity but often still used in developing countries because of low cost
Chloramphenicol
72
Antimicrobials: _Adverse Effects_ * anemia (dose dependent) * aplastic anemia (dose independent) * gray baby syndrome (in premature infants because they lack liver UDP-glucuronosyltransferase)
Chloramphenicol
73
Antimicrobials: _Resistance_ * plasmid-encoded acetyltransferase inactivates the drug
Chloramphenicol
74
Antimicrobials: _Mechanism of Action_ * blocks peptide transfer (translocation) at 50S ribosomal subunit * bacteriostatic
Clindamycin
75
Antimicrobials: _Clinical Use_ * anaerobic infections (eg. *Bacteroides* spp.,*Clostridium perfringens*) in aspiration pneumonia, lung abscesses, and oral * infections * also effective against invasive group A streptococcal infection * treats anaerobic infections above the diaphragm vs. metronidazole
Clindamycin
76
Antimicrobials: _Adverse Effects_ * pseudomembranous colitis (*C. difficile* overgrowth) * fever * diarrhea
Clindamycin
77
Oxazolidinones
Linezolid
78
Antimicrobials: _Mechanism of Action_ * inhibit protein synthesis by binding to 50S subunit and preventing formation of the initiation complex
Oxazolidinones * Linezolid
79
Antimicrobials: _Clinical Use_ * Gram ⊕ * MRSA * VRE
Oxazolidinones * Linezolid
80
Antimicrobials: _Adverse Effects_ * bone marrow suppression (especially thrombocytopenia) * peripheral neuropathy * serotonin syndrome
Oxazolidinones * Linezolid
81
Antimicrobials: _Resistance_ * point mutation of ribosomal RNA
Oxazolidinones * Linezolid
82
Macrolides
* Azithromycin * Clarithromycin * Erythromycin
83
Antimicrobials: _Mechanism of Action_ * inhibit protein synthesis by blocking translocation (“macroslides”) * bind to the 23S rRNA of the 50S ribosomal subunit * bacteriostatic
Macrolides * Azithromycin * Clarithromycin * Erythromycin
84
Antimicrobials: _Clinical Use_ * atypical pneumonias (*Mycoplasma*, *Chlamydia*, *Legionella*) * STIs (*Chlamydia*) * Gram ⊕ Cocci (streptococcal infections in patients allergic to penicillin) * *B. pertussis*
Macrolides * Azithromycin * Clarithromycin * Erythromycin
85
Antimicrobials: _Adverse Effects_ * gastrointestinal motility issues * arrhythmia caused by prolonged QT interval * acute cholestatic hepatitis * rash * eosinophilia * increases serum concentration of theophylline and oral anticoagulants
Macrolides * Azithromycin * Clarithromycin—inhibit cytochrome P-450 * Erythromycin—inhibit cytochrome P-450 **MACRO**: * gastrointestinal **M**otility * **A**rrhythmia * acute **C**holestatic hepatitis * **R**ash * e**O**sinophilia
86
Antimicrobials: _Resistance_ * methylation of 23S rRNA-binding site prevents binding of drug
Macrolides * Azithromycin * Clarithromycin * Erythromycin
87
Polymyxins
* Colistin (Polymyxin E) * Polymyxin B
88
Antimicrobials: _Mechanism of Action_ * cation polypeptides that bind to phospholipids on cell membrane of gram ⊝ bacteria * disrupt cell membrane integrity → leakage of cellular components → cell death
Polymyxins * Colistin (Polymyxin E) * Polymyxin B
89
Antimicrobials: _Clinical Use_ * salvage therapy for multidrug-resistant gram ⊝ bacteria (eg. *P. aeruginosa*, *E. coli*, *K. pneumoniae*)
Polymyxins * Colistin (Polymyxin E) * Polymyxin B—component of a triple antibiotic ointment used for superficial skin infections
90
Antimicrobials: _Adverse Effects_ * nephrotoxicity * neurotoxicity (eg. slurred speech, weakness, paresthesias) * respiratory failure
Polymyxins * Colistin (Polymyxin E) * Polymyxin B
91
Sulfonamides
* Sulfamethoxazole (SMX) * Sulfisoxazole * Sulfadiazine
92
Antimicrobials: _Mechanism of Action_ * inhibit dihydropteroate synthase, thus inhibiting folate synthesis * bacteriostatic (bactericidal when combined with trimethoprim)
Sulfonamides * Sulfamethoxazole (SMX) * Sulfisoxazole * Sulfadiazine
93
Antimicrobials: _Clinical Use_ * Gram ⊕ * Gram ⊝ * *Nocardia*
Sulfonamides * Sulfamethoxazole (SMX) * Sulfisoxazole * Sulfadiazine \*TMP-SMX for simple UTI
94
Antimicrobials: _Adverse Effects_ * hypersensitivity reactions * hemolysis if G6PD deficient * nephrotoxicity (tubulointerstitial nephritis) * photosensitivity * Stevens-Johnson Syndrome * kernicterus in infants * displace other drugs from albumin (eg. warfarin)
Sulfonamides * Sulfamethoxazole (SMX) * Sulfisoxazole * Sulfadiazine
95
Antimicrobials: _Resistance_ * altered enzyme (bacterial dihydropteroate synthase), ↓ uptake, or ↑ PABA synthesis
Sulfonamides * Sulfamethoxazole (SMX) * Sulfisoxazole * Sulfadiazine
96
Antimicrobials: _Mechanism of Action_ * similar to sulfonamides * structurally distinct agent
Dapsone
97
Antimicrobials: _Clinical Use_ * Leprosy (lepromatous and tuberculoid) * *Pneumocystis jirovecii* prophylaxis
Dapsone
98
Antimicrobials: _Adverse Effects_ * hemolysis if G6PD deficient * methemoglobinemia
Dapsone
99
Antimicrobials: _Mechanism of Action_ * inhibits bacterial dihydrofolate reductase * bacteriostatic
Trimethoprim
100
Antimicrobials: _Clinical Use_ * used in combination with sulfonamides * causing sequential block of folate synthesis * combination used for UTIs * *Shigella* * *Salmonella* * *Pneumocystis jirovecii* pneumonia treatment and prophylaxis * *Toxoplasmosis* prophylaxis
Trimethoprim
101
Antimicrobials: _Adverse Effects_ * megaloblastic anemia * leukopenia * granulocytopenia * may be avoided with coadministration of folinic acid
Trimethoprim **TMP** **T**reats **M**arrow **P**oorly.
102
Fluoroquinolones
* Ciprofloxacin * Enoxacin * Norfloxacin * Ofloxacin * Gemifloxacin * Levofloxacin * Moxifloxacin
103
Respiratory Fluoroquinolones
* Gemifloxacin * Levofloxacin * Moxifloxacin
104
Antimicrobials: _Mechanism of Action_ * inhibit prokaryotic enzymes topoisomerase II (DNA gyrase) and topoisomerase IV * bactericidal * must not be taken with antacids
Fluoroquinolones
105
Antimicrobials: _Clinical Use_ * Gram ⊝ Rods of urinary and GI tracts (including *Pseudomonas*) * some gram ⊕ organisms * otitis externa
Fluoroquinolones
106
Antimicrobials: _Adverse Effects_ * GI upset * superinfections * skin rashes * headache * dizziness * less commonly, can cause leg cramps and myalgias * contraindicated in pregnant women, nursing mothers, and children \< 18 years old due to possible damage to cartilage * some may prolong QT interval * tendonitis or tendon rupture in people \> 60 years old and in patients taking prednisone
Fluoroquinolones * Ciprofloxacin —inhibits cytochrome P-450 Fluoroquino**lones** hurt attachments to your **bones**.
107
Antimicrobials: _Resistance_ * chromosome-encoded mutation in DNA gyrase, plasmid-mediated resistance, efflux pumps
Fluoroquinolones
108
Antimicrobials: _Mechanism of Action_ * lipopeptide that disrupts cell membranes of gram ⊕ cocci by creating transmembrane channels
Daptomycin
109
Antimicrobials: _Clinical Use_ * *S. aureus skin* infections (especially MRSA) * bacteremia * endocarditis * VRE * not used for pneumonia (avidly binds to and is inactivated by surfactant)
Daptomycin
110
Antimicrobials: _Adverse Effects_ * myopathy * rhabdomyolysis
Daptomycin
111
Antimicrobials: _Mechanism of Action_ * forms toxic free radical metabolites in the bacterial cell that damage DNA * bactericidal * antiprotozoal
Metronidazole
112
Antimicrobials: _Clinical Use_ * treats *Giardia*, *Entamoeba*, *Trichomonas*, *Gardnerella vaginalis*, Anaerobes (*Bacteroides*, *C. difficile*) * can be used in place of amoxicillin in *H. pylori* “triple therapy” in case of penicillin allergy * treats anaerobic infection below the diaphragm vs. clindamycin (anaerobic infections above diaphragm)
Metronidazole **GET GAP** on the **Metro** with metronidazole! * **G**iardia * **E**ntamoeba * **T**richomonas * **G**ardnerella vaginalis * **A**naerobes (Bacteroides, C. difficile) * H. **P**ylori
113
Antimicrobials: _Adverse Effects_ * Disulfiram-like reaction (severe flushing, tachycardia, hypotension) with alcohol * headache, * metallic taste
Metronidazole
114
Antimycobacterial Drugs: *M. tuberculosis* Prophylaxis
Isoniazid
115
Antimycobacterial Drugs: *M. tuberculosis* Treatment
**RIPE** for Treatment: * **R**ifampin * **I**soniazid * **P**yrazinamide * **E**thambutol
116
Antimycobacterial Drugs: *M. avium–intracellulare* Prophylaxis
* Azithromycin * Rifabutin
117
Antimycobacterial Drugs: *M. avium–intracellulare* Treatment
* Azithromycin or Clarithromycin + Ethambutol * can add Rifabutin or Ciprofloxacin \*More drug resistant than *M. tuberculosis*
118
Antimycobacterial Drugs: *M. leprae* Prophylaxis
N/A
119
Antimycobacterial Drugs: *M. leprae* Treatment
* Tuberculoid * long-term treatment * Dapsone * Rifampin * Lepromatous * add Clofazimine
120
Mycobacterial Cell
121
Rifamycins
* Rifampin * Rifabutin
122
Antimicrobials: _Adverse Effects_ inhibit DNA-dependent RNA polymerase
Rifamycins * Rifampin * Rifabutin Rifampin’s **4 R**’s: * **R**NA polymerase inhibitor * **R**amps up microsomal cytochrome P-450 * **R**ed/orange body fluids * **R**apid resistance if used alone
123
Antimicrobials: _Clinical Use_ * *Mycobacterium tuberculosis* * delay resistance to Dapsone when used for leprosy * used for meningococcal prophylaxis and chemoprophylaxis in contacts of children with *H. influenzae* type b
Rifamycins * Rifampin * Rifabutin
124
Antimicrobials: _Adverse Effects_ * minor hepatotoxicity and drug interactions (↑ cytochrome P-450) * orange body fluids (nonhazardous side effect)
Rifamycins * Rifampin * Rifabutin—favored in patients with HIV infection due to less cytochrome P-450 stimulation **Rifampin**’s **4 R**’s: * **R**NA polymerase inhibitor * **R**amps up microsomal cytochrome P-450 * **R**ed/orange body fluids * **R**apid resistance if used alone **R**if**amp**in **ramp**s up cytochrome P-450, **but** rifa**but**in does not.
125
Antimicrobials: _Resistance_ * mutations reduce drug binding to RNA polymerase * monotherapy rapidly leads to resistance
Rifamycins * Rifampin * Rifabutin **Rifampin**’s **4 R**’s: * **R**NA polymerase inhibitor * **R**amps up microsomal cytochrome P-450 * **R**ed/orange body fluids * **R**apid resistance if used alone
126
Antimicrobials: _Mechanism of Action_ * ↓ synthesis of mycolic acids * bacterial catalase-peroxidase (encoded by KatG) needed to convert INH to active metabolite
Isoniazid
127
Antimicrobials: _Clinical Use_ * *Mycobacterium tuberculosis* * the only agent used as solo prophylaxis against TB * also used as monotherapy for latent TB * different half-lives in fast vs. slow acetylators
Isoniazid
128
Antimicrobials: _Adverse Effects_ * hepatotoxicity * P-450 inhibition * drug-induced SLE * anion gap metabolic acidosis * vitamin B6 deficiency (peripheral neuropathy, sideroblastic anemia) * administer with Pyridoxine (B6)
Isoniazid **INH** **I**njures **N**eurons and **H**epatocytes.
129
Antimicrobials: _Resistance_ * mutations leading to underexpression of KatG
Isoniazid
130
Antimicrobials: _Mechanism of Action_ * uncertain * a prodrug that is converted to the active compound Pyrazinoic acid * works best at acidic pH (eg. in host phagolysosomes)
Pyrazinamide
131
Antimicrobials: _Adverse Effects_ * hyperuricemia * hepatotoxicity
Pyrazinamide
132
Antimicrobials: _Mechanism of Action_ * ↓ carbohydrate polymerization of mycobacterium cell wall by blocking arabinosyltransferase
Ethambutol
133
Antimicrobials: _Adverse Effects_ * optic neuropathy (red-green color blindness)
Ethambutol **Eye**thambutol
134
Antimicrobials: _Mechanism of Action_ * interferes with 30S component of ribosome
Streptomycin
135
Antimicrobials: _Adverse Effects_ * tinnitus * vertigo * ataxia * nephrotoxicity
Streptomycin
136
Antimicrobials: _Clinical Use_ * *Mycobacterium tuberculosis*
* Pyrazinamide * Ethambutol * Streptomycin (2nd line)
137
Antimicrobial Prophylaxis: high risk for endocarditis and undergoing surgical or dental procedures
Amoxicillin
138
Antimicrobial Prophylaxis: exposure to gonorrhea
Ceftriaxone
139
Antimicrobial Prophylaxis: history of recurrent UTIs
TMP-SMX
140
Antimicrobial Prophylaxis: exposure to meningococcal infection
* Ceftriaxone * Ciprofloxacin * Rifampin
141
Antimicrobial Prophylaxis: pregnant woman carrying group B strep
* Penicillin G * Ampicillin
142
Antimicrobial Prophylaxis: prevention of gonococcal conjunctivitis in newborn
Erythromycin eye ointment
143
Antimicrobial Prophylaxis: prevention of postsurgical infection due to *S. aureus*
Cefazolin
144
Antimicrobial Prophylaxis: prophylaxis of strep pharyngitis in child with prior rheumatic fever
* Benzathine Penicillin G * Oral Penicillin V
145
Antimicrobial Prophylaxis: exposure to syphilis
Benzathine Penicillin G
146
Prophylaxis in HIV patients: * CD4 \< 200 cells/mm3 * *Pneumocystis* pneumonia
TMP-SMX
147
Prophylaxis in HIV patients: * CD4 \< 100 cells/mm3 * *Pneumocystis* pneumonia * *Toxoplasmosis*
TMP-SMX
148
Prophylaxis in HIV patients: * CD4 \< 50 cells/mm3 * *Mycobacterium avium* Complex
* Azithromycin * Clarithromycin
149
Treatment of Highly Resistant Bacteria: MRSA
* Vancomycin * Daptomycin * Linezolid * Tigecycline * Ceftaroline * Doxycycline
150
Treatment of Highly Resistant Bacteria: VRE
* Linezolid * Streptogramins (Quinupristin, Dalfopristin)
151
Treatment of Highly Resistant Bacteria: Multidrug-Resistant *P. aeruginosa*
* Polymyxin B * Polymyxin E (Colistin)
152
Treatment of Highly Resistant Bacteria: Multidrug-Resistant *Acinetobacter baumannii*
* Polymyxin B * Polymyxin E (Colistin)
153
Antifungal Therapy
154
Antimicrobials: _Mechanism of Action_ * binds ergosterol (unique to fungi) * forms membrane pores that allow leakage of electrolytes
Amphotericin B Ampho**ter**icin “**tear**s” holes in the fungal membrane by forming pores.
155
Antimicrobials: _Clinical Use_ * serious, systemic mycoses * *Cryptococcus* (amphotericin B with/without flucytosine for cryptococcal meningitis) * *Blastomyces* * *Coccidioides* * *Histoplasma* * *Candida* * *Mucor* * intrathecally for fungal meningitis * supplement K+ and Mg2+ because of altered renal tubule permeability
Amphotericin B
156
Antimicrobials: _Adverse Effects_ * fever/chills (“shake and bake”) * hypotension * nephrotoxicity * arrhythmias * anemia * IV phlebitis * hydration ↓ nephrotoxicity * liposomal form ↓ toxicity
Amphotericin B
157
Antimicrobials: _Mechanism of Action_ * same as Amphotericin B * topical use only as too toxic for systemic use
Nystatin
158
Antimicrobials: _Clinical Use_ * “swish and swallow” for oral candidiasis (thrush) * topical for diaper rash or vaginal candidiasis
Nystatin
159
Antimicrobials: _Mechanism of Action_ * inhibits DNA and RNA biosynthesis by conversion to 5-fluorouracil by cytosine deaminase
Flucytosine
160
Antimicrobials: _Clinical Use_ * systemic fungal infections (especially meningitis caused by *Cryptococcus*) in combination with amphotericin B
Flucytosine
161
Antimicrobials: _Adverse Effects_ * bone marrow suppression
Flucytosine
162
Azoles
* Clotrimazole * Fluconazole * Isavuconazole * Itraconazole * Ketoconazole * Miconazole * Voriconazole
163
Antimicrobials: _Mechanism of Action_ * inhibit fungal sterol (ergosterol) synthesis by inhibiting the cytochrome P-450 enzyme that converts lanosterol to ergosterol
Azoles
164
Antimicrobials: _Clinical Use_ * local and less serious systemic mycoses
Azoles
165
Antimicrobials: _Clinical Use_ * for chronic suppression of cryptococcal meningitis in AIDS patients and candidal infections of all types
Fluconazole
166
Antimicrobials: _Clinical Use_ * *Blastomyces* * *Coccidioides* * *Histoplasma*
Itraconazole
167
Antimicrobials: _Clinical Use_ * topical fungal infections
* Clotrimazole * Miconazole
168
Antimicrobials: _Clinical Use_ * *Aspergillus* * *Candida*
Voriconazole
169
Antimicrobials: _Clinical Use_ * *Aspergillus* * *Mucor*
Isavuconazole
170
Antimicrobials: _Adverse Effects_ * testosterone synthesis inhibition (gynecomastia) * liver dysfunction (inhibits cytochrome P-450)
Azoles Ketoconazole—gynecomastia
171
Antimicrobials: _Mechanism of Action_ * inhibits the fungal enzyme squalene epoxidase
Terbinafine
172
Antimicrobials: _Clinical Use_ * dermatophytoses (especially onychomycosis—fungal infection of finger or toe nails)
Terbinafine
173
Antimicrobials: _Adverse Effects_ * GI upset * headaches * hepatotoxicity * taste disturbance
Terbinafine
174
Echinocandins
* Anidulafungin * Caspofungin * Micafungin
175
Antimicrobials: Mechanism of Action * inhibit cell wall synthesis by inhibiting synthesis of β-glucan
Echinocandins * Anidulafungin * Caspofungin * Micafungin
176
Antimicrobials: _Clinical Use_ * invasive aspergillosis * *Candida*
Echinocandins * Anidulafungin * Caspofungin * Micafungin
177
Antimicrobials: _Adverse Effects_ * GI upset * flushing (by histamine release)
Echinocandins * Anidulafungin * Caspofungin * Micafungin
178
Antimicrobials: _Mechanism of Action_ * interferes with microtubule function * disrupts mitosis * deposits in keratin-containing tissues (eg. nails)
Griseofulvin
179
Antimicrobials: _Clinical Use_ * oral treatment of superficial infections * inhibits growth of dermatophytes (tinea, ringworm)
Griseofulvin
180
Antimicrobials: _Adverse Effects_ * teratogenic * carcinogenic * confusion * headaches * disulfiram-like reaction * ↑ cytochrome P-450 and warfarin metabolism
Griseofulvin
181
Antiprotozoal Therapy: Toxoplasmosis
Pyrimethamine
182
Antiprotozoal Therapy: ## Footnote *Trypanosoma brucei*
* Suramin * Melarsoprol
183
Antiprotozoal Therapy: Trypanosoma cruzi
Nifurtimox
184
Antiprotozoal Therapy: Leishmaniasis
Sodium Stibogluconate
185
Anti-Mite/Louse Therapy
* Permethrin * ​inhibits Na+ channel deactivation → neuronal membrane depolarization) * Malathion * acetylcholinesterase inhibitor * Lindane * blocks GABA channels → neurotoxicity \*used to treat scabies (*Sarcoptes scabiei*) and lice (*Pediculus* and *Pthirus*) Treat **PML** (**P**esty **M**ites and **L**ice) with **PML** (**P**ermethrin, **M**alathion, **L**indane), because they **NAG** you (**N**a, **A**ChE, **G**ABA blockade).
186
Antimicrobials: _Mechanism of Action_ * blocks detoxification of heme into hemozoin * heme accumulates and is toxic to plasmodia
Chloroquine
187
Antimicrobials: _Clinical Use_ * treatment of plasmodial species other than *P. falciparum* (frequency of resistance is too high) * resistance due to membrane pump that ↓ intracellular concentration of drug
Chloroquine
188
Antimicrobials: _Adverse Effects_ * retinopathy * pruritus (especially in dark-skinned individuals)
Chloroquine
189
Antimicrobials: _Clinical Use_ * *P. falciparum*
* Artemether/Lumefantrine * Atovaquone/Proguanil
190
Antimicrobials: _Clinical Use_ * life-threatening malaria
* Quinidine—US * Quinine * Artesunate
191
Antihelminthic Therapy
Helminths get **PIMP’D**. * **P**yrantel pamoate * **I**vermectin * **M**ebendazole (microtubule inhibitor) * **P**raziquantel * **D**iethylcarbamazine.
192
Antiviral Therapy
193
Antimicrobials: _Mechanism of Action_ * inhibit influenza neuraminidase → ↓ release of progeny virus
* Oseltamivir * Zanamivir
194
Antimicrobials: _Clinical Use_ * treatment and prevention of both influenza A and B * beginning therapy within 48 hours of symptom onset may shorten duration of illness
* Oseltamivir * Zanamivir
195
Antimicrobials: _Mechanism of Action_ * guanosine analogs * monophosphorylated by HSV/VZV thymidine kinase and not phosphorylated in uninfected cells → few adverse effects * triphosphate formed by cellular enzymes * preferentially inhibit viral DNA polymerase by chain termination
* Acyclovir * Famciclovir * Valacyclovir
196
Antimicrobials: _Clinical Use_ * HSV and VZV * weak activity against EBV * no activity against CMV * used for HSV-induced mucocutaneous and genital lesions as well as for encephalitis * prophylaxis in immunocompromised patients * no effect on latent forms of HSV and VZV
* Acyclovir * Famciclovir—herpes zoster * Valacyclovir—prodrug of acyclovir, better oral bioavailability
197
Antimicrobials: _Adverse Effects_ * obstructive crystalline nephropathy and acute renal failure if not adequately hydrated
* Acyclovir * Famciclovir * Valacyclovir
198
Antimicrobials: _Resistance_ * mutated viral thymidine kinase
* Acyclovir * Famciclovir * Valacyclovir
199
Antimicrobials: _Mechanism of Action_ * 5′-monophosphate formed by a CMV viral kinase * Guanosine analog * triphosphate formed by cellular kinases * preferentially inhibits viral DNA polymerase
Ganciclovir
200
Antimicrobials: _Clinical Use_ * CMV * immunocompromised patients
Ganciclovir \*Valganciclovir—prodrug of ganciclovir, better oral bioavailability
201
Antimicrobials: _Adverse Effects_ * bone marrow suppression (leukopenia, neutropenia, thrombocytopenia) * renal toxicity * more toxic to host enzymes than acyclovir
Ganciclovir
202
Antimicrobials: _Resistance_ * mutated viral kinase
Ganciclovir
203
Antimicrobials: _Mechanism of Action_ * Pyrofosphate analog * viral DNA/RNA polymerase inhibitor and HIV reverse transcriptase inhibitor * binds to pyrophosphate-binding site of enzyme * does not require any kinase activation
Foscarnet **Fos**carnet = pyro**fos**phate analog
204
Antimicrobials: _Clinical Use_ * CMV retinitis in immunocompromised patients when Ganciclovir fails * Acyclovir-resistant HSV
Foscarnet
205
Antimicrobials: _Adverse Effects_ * nephrotoxicity * electrolyte abnormalities (hypo- or hypercalcemia, hypo- or hyperphosphatemia, hypokalemia, hypomagnesemia) can lead to seizures
Foscarnet
206
Antimicrobials: _Resistance_ * mutated DNA polymerase
Foscarnet
207
Antimicrobials: _Mechanism of Action_ * preferentially inhibits viral DNA polymerase * does not require phosphorylation by viral kinase
Cidofovir
208
Antimicrobials: _Clinical Use_ * CMV retinitis in immunocompromised patients * Acyclovir-resistant HSV * long half-life
Cidofovir
209
Antimicrobials: _Adverse Effects_ * nephrotoxicity (coadminister with probenecid and IV saline to ↓ toxicity)
Cidofovir
210
HIV Therapy
Highly Active Antiretroviral Therapy (HAART) \*often initiated at the time of HIV diagnosis
211
Strongest Indication for HAART
* low CD4+ cell counts (\< 500 cells/mm3) * high viral load
212
Highly Active Antiretroviral Therapy (HAART) regimen consists of \_\_\_\_\_.
3 drugs to prevent resistance * 2 NRTIs * an integrase inhibitor
213
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
* Abacavir (ABC) * Didanosine (ddI) * Emtricitabine (FTC) * Lamivudine (3TC) * Stavudine (d4T) * Tenofovir (TDF) * Zidovudine (ZDV, formerly AZT)
214
HIV Therapy: * competitively inhibit nucleotide binding to reverse transcriptase and terminate the DNA chain (lack a 3′ OH group) * need to be phosphorylated to be active
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) **T**enofovir is a nucleo**T**ide; the others are nucleosides.
215
HIV Therapy: can be used for general prophylaxis and during pregnancy to ↓ risk of fetal transmission
Zidovudine (ZDV, formerly AZT)
216
HIV Therapy: * bone marrow suppression (can be reversed with granulocyte colony-stimulating factor [G-CSF] and erythropoietin) * peripheral neuropathy * lactic acidosis (nucleosides) * anemia (ZDV) * pancreatitis (Didanosine)
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
217
HIV Therapy: contraindicated if patient has HLA-B\*5701 mutation due to ↑ risk of hypersensitivit
Abacavir
218
Non-Nucleoside Reverse-Transcriptase Inhibitors (NNRTIs)
* Delavirdine * Efavirenz * Nevirapine
219
HIV Therapy: * bind to reverse transcriptase at site different from NRTIs * do not require phosphorylation to be active or compete with nucleotides * rash and hepatotoxicity are common
Non-Nucleoside Reverse-Transcriptase Inhibitors (NNRTIs)
220
HIV Therapy: vivid dreams and CNS symptoms are commo
Efavirenz
221
HIV Therapy: NNRTIs contraindicated in pregnancy
* Delavirdine * Efavirenz
222
Protease Inhibitors
* Atazanavir * Darunavir * Fosamprenavir * Indinavir * Lopinavir * Ritonavir * Saquinavir **Navir** (never) **tease** a pro**tease**.
223
HIV Therapy: * assembly of virions depends on HIV-1 protease (pol gene), which cleaves the polypeptide products of HIV mRNA into their functional parts * prevent maturation of new viruses * hyperglycemia, GI intolerance (nausea, diarrhea), lipodystrophy (Cushing-like syndrome)
Protease Inhibitors
224
HIV Therapy: can “boost” other drug concentrations by inhibiting cytochrome P-450
Ritonavir
225
HIV Therapy: * nephropathy * hematuria * thrombocytopenia
Indinavir
226
HIV Therapy: * potent CYP/UGT inducer * reduces protease inhibitor concentrations
Rifampin \*use rifabutin instead
227
Integrase Inhibitors
* Dolutegravir * Elvitegravir * Raltegravir
228
HIV Therapy: * inhibits HIV genome integration into host cell chromosome by reversibly inhibiting HIV integrase * ↑ creatine kinase
Integrase Inhibitors
229
Fusion Inhibitors
* Enfuvirtide * Maraviroc
230
HIV Therapy: * binds gp41, inhibiting viral entry * skin reaction at injection sites
Enfuvirtide En**fu**virtide inhibits **fu**sion.
231
HIV Therapy: * binds CCR-5 on surface of T cells/monocytes * inhibits interaction with gp120
Maraviroc Maravir**oc** inhibits d**oc**king.
232
Antimicrobials: _Mechanism of Action_ * glycoproteins normally synthesized by virus-infected cells, exhibiting a wide range of antiviral and antitumoral properties
Interferons
233
Antimicrobials: _Clinical Use_ * chronic HBV and HVC * Kaposi sarcoma * hairy cell leukemia * condyloma acuminatum * renal cell carcinoma * malignant melanoma * multiple sclerosis * chronic granulomatous disease
Interferons
234
Antimicrobials: _Adverse Effects_ * flu-like symptoms * depression * neutropenia * myopathy
Interferons
235
Antimicrobials: * Hepatitis C * viral phosphoprotein (NS5A) inhibitor * NS5A plays important role in replication
Ledipasvir
236
Antimicrobials: * Hepatitis C * inhibits synthesis of guanine nucleotides by competitively inhibiting inosine monophosphate dehydrogenase * hemolytic anemia * severe teratogen
Ribavirin
237
Antimicrobials: * Hepatitis C * HCV protease (NS3/4A) * prevents viral replication * photosensitivity reactions * rash
Simeprevir
238
Antimicrobials: * Hepatitis C * inhibits HCV RNA-dependent RNA polymerase (NS5B) acting as a chain terminator * fatigue * headache * nausea
Sofosbuvir
239
\_\_\_\_\_ is the reduction of pathogenic organism counts to safe levels.
Disinfection
240
\_\_\_\_\_ the inactivation of all microbes including spores.
Sterilization
241
Disinfection and Sterilization: * pressurized steam at \> 120°C * sporicidal * may not reliably inactivate prions
Autoclave
242
Disinfection and Sterilization: * denature proteins and disrupt cell membranes * not sporicidal
* Alcohols * Chlorhexidine
243
Disinfection and Sterilization: * oxidizes and denatures proteins * sporicidal
Chlorine
244
Disinfection and Sterilization: * free radical oxidation * sporicidal
Hydrogen Peroxide
245
Disinfection and Sterilization: * halogenation of DNA, RNA, and proteins * may be sporicidal
* Iodine * Iodophors
246
Disinfection and Sterilization: * impair permeability of cell membranes * not sporicidal
Quaternary Amines
247
Antimicrobials to Avoid in Pregnancy
**T**ake **R**eally **G**ood **C**are to keep **C**hildren **SAF**e. * **T**etracyclines * **R**ibavirin * **G**riseofulvin * **C**hloramphenicol * **C**larithromycin * **S**ulfonamides * **A**minoglycosides * **F**luoroquinolones
248
Antimicrobials to Avoid in Pregnancy: * discolored teeth * inhibition of bone growth
Tetracyclines
249
Antimicrobials to Avoid in Pregnancy: teratogenic
* Ribavirin * Griseofulvin
250
Antimicrobials to Avoid in Pregnancy: Gray Baby Syndrome
Chloramphenicol
251
Antimicrobials to Avoid in Pregnancy: embryotoxic
Clarithromycin
252
Antimicrobials to Avoid in Pregnancy: kernicterus
Sulfonamides
253
Antimicrobials to Avoid in Pregnancy: ototoxicity
Aminoglycosides
254
Antimicrobials to Avoid in Pregnancy: cartilage damage
Fluoroquinolones